G.T. Gevasol Technologies Ltd.
Plant certified by the Brazilian health regulator (ANVISA)
ANVISA, the Brazilian health regulator, holds a valid Good Manufacturing Practice certificate for this plant, covering medical devices, valid until 2027-01-13. The certificate is issued after an inspection of the plant itself, which is why a foreign regulator names this site: goods made here are allowed on the Brazilian market. The certificate records the site address as 11, HA'SADNA ST. , BEIT SHE'AN, ISRAEL. Process number 25351372558202411.
- Type
- brand seeking distribution
- Location
- Beit She'An, Israel
- Categories
- चिकित्सा एवं स्वास्थ्य देखभाल आपूर्तियाँ
- Markets
- इज़राइल, ब्राज़ील
Listed in a source registry
Verified facts
- manufacturing-practice-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- sanctions-clear (green), checked 2026-09-02 OpenSanctions
- debarment-clear (green), checked 2026-09-02 OpenSanctions
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)